These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. Jakubowski JA; Winters KJ; Naganuma H; Wallentin L Cardiovasc Drug Rev; 2007; 25(4):357-74. PubMed ID: 18078435 [TBL] [Abstract][Full Text] [Related]
10. [Prasugrel, a new thienopyridine]. Schrör K; Huber K Hamostaseologie; 2007 Dec; 27(5):351-5. PubMed ID: 18060245 [TBL] [Abstract][Full Text] [Related]
11. Prasugrel: a novel antiplatelet agent. Riley AB; Tafreshi MJ; Haber SL Am J Health Syst Pharm; 2008 Jun; 65(11):1019-28. PubMed ID: 18499874 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. Niitsu Y; Jakubowski JA; Sugidachi A; Asai F Semin Thromb Hemost; 2005 Apr; 31(2):184-94. PubMed ID: 15852222 [TBL] [Abstract][Full Text] [Related]
13. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]